NCT00868634 Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00858429 Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases Status COMPLETED Phase PHASE1
NCT00854477 Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE4
NCT00848783 Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers Status TERMINATED Phase PHASE2
NCT00842491 Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT00842244 Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1
NCT00829166 A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00828672 Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00820222 Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00814619 Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00812864 Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years) Status COMPLETED Phase PHASE4
NCT00798252 Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers Status COMPLETED Phase PHASE1
NCT00797485 Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE3
NCT00789958 S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Status COMPLETED Phase PHASE2
NCT00787787 Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer Status TERMINATED Phase PHASE2
NCT00780494 Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma Status COMPLETED Phase PHASE2
NCT00777101 Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Status COMPLETED Phase PHASE2